MedCity News
NOVEMBER 23, 2023
With proposed requirements ranging from accessible self-service kiosks to accessible medical equipment, the impact of this new rule will be wide-ranging with financial, operational, and practical consequences.
pharmaphorum
NOVEMBER 23, 2023
US biotech Moderna has completed the installation of its clinical laboratories at its new R&D facility in the UK dedicated to the discovery of new mRNA vaccines and therapeutics, part of a 10-year partnership with the government agreed last year that has been estimated to be worth around £1 billion.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MedCity News
NOVEMBER 23, 2023
Proposals targeting misaligned financial incentives, price transparency, and pharmacy access are important and necessary reforms. But the consequences of failing to address pharmacy benefit managers’ use of market power to block competition and extract monopoly profits from payers and consumers will not be limited to drug costs – it will change all of healthcare for generations.
European Pharmaceutical Review
NOVEMBER 23, 2023
Following the UK government’s recent announcement of a £520 million funding boost for UK manufacturing, a new Oligonucleotide Manufacturing Innovation Centre of Excellence in Scotland will develop innovative and sustainable techniques for these medicines. According to the Centre for Process Innovation (CPI), oligonucleotides therapeutics use short, chemically synthesised fragments of DNA or RNA to modulate protein expression and ultimately treat the underlying cause of disease.
Pharmaceutical Technology
NOVEMBER 23, 2023
T3 Pharma uses a bacterial secretion system for the delivery of immune-modulating proteins to cancer cells and tumour micro-environments.
PharmaTimes
NOVEMBER 23, 2023
Both companies will use their platforms to accelerate drug discovery and development - News - PharmaTimes
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
European Pharmaceutical Review
NOVEMBER 23, 2023
Last month at CPHI Barcelona 2023 , EPR interviewed Mohamed Noor, Digitalization Manager at the National Institute for Bioprocessing Research and Training ( NIBRT ). During the conversation, Noor shed light on how digitalisation is impacting the biopharmaceutical industry. Additionally, he explored the trends, challenges and opportunities for process analytical technology (PAT).
pharmaphorum
NOVEMBER 23, 2023
Lord James O’Shaughnessy has welcomed the UK government’s official response to his review of commercial clinical trials, saying there have been a number of positive developments since it was published in the spring.
Impetus Digital
NOVEMBER 23, 2023
A version of this article was previously published in the Journal of mHealth. With the end of the year quickly approaching, you will likely see multiple articles on the key trends of 2023 and predictions for 2024 start popping up. Many of these will discuss the expanding role and capabilities of AI and machine learning in the Pharma space. Others might talk about the return of in-person meetings after the COVID-19 pandemic.
Clarivate
NOVEMBER 23, 2023
As AI becomes part of the fabric of our personal and professional lives, its use continues to reveal both its potential and limitations. The speed and accuracy of drug discovery and development are being transformed by AI and machine learning (ML) applications. AI and life science companies alike need to conduct due diligence to ensure optimal results and avoid the pitfalls of poor data sources and an over-reliance on technology’s capabilities.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
pharmaphorum
NOVEMBER 23, 2023
Novo Nordisk will invest €2.1bn in French manufacturing site Phil.
Pharmaceutical Technology
NOVEMBER 23, 2023
EirGenix and Sandoz's biosimilar has been approved for all the indications as the reference biologic, Roche’s Herceptin.
pharmaphorum
NOVEMBER 23, 2023
InDex craters on phase 3 ulcerative colitis failure Phil.
Pharmaceutical Technology
NOVEMBER 23, 2023
SK bioscience has signed an agreement with Hilleman Laboratories Singapore for the co-development of a vaccine against the Zaire Ebola virus.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
PharmaTech
NOVEMBER 23, 2023
Chris Spivey, editorial director for Pharmaceutical Technology and Biopharm International, spoke with Concetto Andrea Rizza, Marketing and Communications manager, ICE Pharma, on sustainability and ICE’s green approach at CPhI Barcelona 2023.
Pharmaceutical Technology
NOVEMBER 23, 2023
The fast track designation for the paediatric multi-food allergy therapy ADP101 was based on the Phase I/II data.
PharmaTech
NOVEMBER 23, 2023
Hovione has acquired start-up company, ExtremoChem, expanding its technology platforms.
Pharmaceutical Technology
NOVEMBER 23, 2023
China’s NMPA has accepted NDA for AnHeart Therapeutics taletrectinib to treat locally advanced or metastatic ROS1-positive NSCLC.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
PharmaTech
NOVEMBER 23, 2023
UK industry body, ABPI, has responded positively to the recent Autumn Statement.
Pharmaceutical Technology
NOVEMBER 23, 2023
When expectant mothers are diagnosed with gestational diabetes mellitus (GDM) they often feel anxious and need extra support.
Pharmacy Times
NOVEMBER 23, 2023
Pediatric individuals that are higher risk for APS must be followed to better understand affects
Pharmaceutical Technology
NOVEMBER 23, 2023
Simcere will have the rights to develop and commercialise rademikibart in mainland China, Macau, Taiwan, and Hong Kong.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
European Pharmaceutical Review
NOVEMBER 23, 2023
Boehringer Ingelheim is acquiring Swiss biotech T3 Pharmaceuticals AG (T3 Pharma), for up to £406 million (450 million CHF), boosting its immuno-oncology portfolio. The pharmaceutical company will utilise T3 Pharmaceutical’s proprietary bacterial cancer therapy platform that consisting that delivers immune-modulating bioactive proteins to cancer cells and tumour micro-environments.
Pharmaceutical Technology
NOVEMBER 23, 2023
Syncona has signed a definitive agreement to acquire clinical-stage biotechnology company Freeline Therapeutics
PharmaTimes
NOVEMBER 23, 2023
ADP101 is an oral immunotherapy to treat multi-food and single-food allergies - News - PharmaTimes
Pharmaceutical Technology
NOVEMBER 23, 2023
Biotech company Vivodyne has raised $38m in total seed financing for the development of lab-grown human organs.
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
Expert insights. Personalized for you.
126 
Let's personalize your content